
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1290345
[patent_doc_number] => 06632925
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-14
[patent_title] => 'Biodegradable plant protein composites and related methods'
[patent_app_type] => B1
[patent_app_number] => 09/564005
[patent_app_country] => US
[patent_app_date] => 2000-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6267
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/632/06632925.pdf
[firstpage_image] =>[orig_patent_app_number] => 09564005
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/564005 | Biodegradable plant protein composites and related methods | May 2, 2000 | Issued |
Array
(
[id] => 1345439
[patent_doc_number] => 06582949
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-24
[patent_title] => 'Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/563505
[patent_app_country] => US
[patent_app_date] => 2000-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11580
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/582/06582949.pdf
[firstpage_image] =>[orig_patent_app_number] => 09563505
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/563505 | Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof | May 2, 2000 | Issued |
Array
(
[id] => 1602501
[patent_doc_number] => 06432680
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Sequence and method for genetic engineering of proteins with cell membrane translocating activity'
[patent_app_type] => B1
[patent_app_number] => 09/562868
[patent_app_country] => US
[patent_app_date] => 2000-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 12359
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432680.pdf
[firstpage_image] =>[orig_patent_app_number] => 09562868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/562868 | Sequence and method for genetic engineering of proteins with cell membrane translocating activity | Apr 30, 2000 | Issued |
Array
(
[id] => 856826
[patent_doc_number] => 07375085
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-05-20
[patent_title] => 'Melanocyte-stimulating hormone inhibitors'
[patent_app_type] => utility
[patent_app_number] => 09/926391
[patent_app_country] => US
[patent_app_date] => 2000-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8469
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375085.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926391
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926391 | Melanocyte-stimulating hormone inhibitors | Apr 24, 2000 | Issued |
Array
(
[id] => 948869
[patent_doc_number] => 06962905
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-08
[patent_title] => 'Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug'
[patent_app_type] => utility
[patent_app_number] => 09/582863
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4588
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962905.pdf
[firstpage_image] =>[orig_patent_app_number] => 09582863
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/582863 | Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug | Apr 18, 2000 | Issued |
| 09/551147 | Enzyme-activated anti-tumor prodrug compounds | Apr 14, 2000 | Abandoned |
Array
(
[id] => 1549848
[patent_doc_number] => 06399330
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'Bacillus thuringiensis cryet33 and cryet34 compositions and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/549839
[patent_app_country] => US
[patent_app_date] => 2000-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 26519
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399330.pdf
[firstpage_image] =>[orig_patent_app_number] => 09549839
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/549839 | Bacillus thuringiensis cryet33 and cryet34 compositions and uses thereof | Apr 13, 2000 | Issued |
Array
(
[id] => 1502373
[patent_doc_number] => 06464986
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Method for treating pain by peripheral administration of a neurotoxin'
[patent_app_type] => B1
[patent_app_number] => 09/550371
[patent_app_country] => US
[patent_app_date] => 2000-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14568
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/464/06464986.pdf
[firstpage_image] =>[orig_patent_app_number] => 09550371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/550371 | Method for treating pain by peripheral administration of a neurotoxin | Apr 13, 2000 | Issued |
Array
(
[id] => 1287002
[patent_doc_number] => 06639050
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins'
[patent_app_type] => B1
[patent_app_number] => 09/547693
[patent_app_country] => US
[patent_app_date] => 2000-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 44827
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/639/06639050.pdf
[firstpage_image] =>[orig_patent_app_number] => 09547693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/547693 | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins | Apr 11, 2000 | Issued |
Array
(
[id] => 1281556
[patent_doc_number] => 06642203
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Crustacean antimicrobial peptides'
[patent_app_type] => B1
[patent_app_number] => 09/463125
[patent_app_country] => US
[patent_app_date] => 2000-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6842
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642203.pdf
[firstpage_image] =>[orig_patent_app_number] => 09463125
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/463125 | Crustacean antimicrobial peptides | Apr 11, 2000 | Issued |
Array
(
[id] => 1314440
[patent_doc_number] => 06610821
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Compounds and methods for modulating endothelial cell adhesion'
[patent_app_type] => B1
[patent_app_number] => 09/544782
[patent_app_country] => US
[patent_app_date] => 2000-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 34
[patent_no_of_words] => 23225
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610821.pdf
[firstpage_image] =>[orig_patent_app_number] => 09544782
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/544782 | Compounds and methods for modulating endothelial cell adhesion | Apr 6, 2000 | Issued |
| 09/529106 | MUTANTS OF YEAST CDC24P, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT | Apr 6, 2000 | Abandoned |
Array
(
[id] => 4411433
[patent_doc_number] => 06310186
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Purification of biological preparations'
[patent_app_type] => 1
[patent_app_number] => 9/541815
[patent_app_country] => US
[patent_app_date] => 2000-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4022
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310186.pdf
[firstpage_image] =>[orig_patent_app_number] => 541815
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/541815 | Purification of biological preparations | Apr 2, 2000 | Issued |
Array
(
[id] => 1371348
[patent_doc_number] => 06566500
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Compositions and methods for modifying toxic effects of proteinaceous compounds'
[patent_app_type] => B1
[patent_app_number] => 09/538873
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 31527
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566500.pdf
[firstpage_image] =>[orig_patent_app_number] => 09538873
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538873 | Compositions and methods for modifying toxic effects of proteinaceous compounds | Mar 29, 2000 | Issued |
Array
(
[id] => 1169582
[patent_doc_number] => 06753314
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'Protein-protein complexes and methods of using same'
[patent_app_type] => B1
[patent_app_number] => 09/538092
[patent_app_country] => US
[patent_app_date] => 2000-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38441
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753314.pdf
[firstpage_image] =>[orig_patent_app_number] => 09538092
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538092 | Protein-protein complexes and methods of using same | Mar 28, 2000 | Issued |
Array
(
[id] => 1362963
[patent_doc_number] => 06569831
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Recombinant lactoferrin, methods of production from plants and uses'
[patent_app_type] => B1
[patent_app_number] => 09/423097
[patent_app_country] => US
[patent_app_date] => 2000-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14165
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569831.pdf
[firstpage_image] =>[orig_patent_app_number] => 09423097
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423097 | Recombinant lactoferrin, methods of production from plants and uses | Mar 20, 2000 | Issued |
Array
(
[id] => 1241231
[patent_doc_number] => 06683054
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Use of melagatran'
[patent_app_type] => B1
[patent_app_number] => 09/508762
[patent_app_country] => US
[patent_app_date] => 2000-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2397
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/683/06683054.pdf
[firstpage_image] =>[orig_patent_app_number] => 09508762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508762 | Use of melagatran | Mar 15, 2000 | Issued |
Array
(
[id] => 1474928
[patent_doc_number] => 06387878
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Methods of treating intestinal ischemia using heparin-binding epidermal growth factor'
[patent_app_type] => B1
[patent_app_number] => 09/518950
[patent_app_country] => US
[patent_app_date] => 2000-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7257
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387878.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518950
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518950 | Methods of treating intestinal ischemia using heparin-binding epidermal growth factor | Mar 5, 2000 | Issued |
Array
(
[id] => 516818
[patent_doc_number] => 07189506
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-03-13
[patent_title] => 'DNA binding compound-mediated molecular switch system'
[patent_app_type] => utility
[patent_app_number] => 09/518297
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 31861
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189506.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518297
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518297 | DNA binding compound-mediated molecular switch system | Mar 2, 2000 | Issued |
Array
(
[id] => 1312790
[patent_doc_number] => 06610658
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Modulators of -amyloid peptide aggregation'
[patent_app_type] => B1
[patent_app_number] => 09/519019
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26141
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610658.pdf
[firstpage_image] =>[orig_patent_app_number] => 09519019
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/519019 | Modulators of -amyloid peptide aggregation | Mar 2, 2000 | Issued |